macro

STAAR Surgical Average Price Target Cut to $28.14

Analysts lowered the average 12-month price target for STAAR Surgical shares from $29.25 to $28.14. The consensus rating remains at Hold.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

According to estimates from seven analysts, the average 12-month price target for STAAR Surgical shares fell from $29.25 to $28.14. Forecasts range from $19 to $34 per share.

According to TradingView, citing FactSet data, the updated target implies roughly 16% potential upside from the November 20 closing price. The consensus rating remains Hold across nine covering analysts: two Buys, six Holds and one Sell.

why it matters

Routine target revisions like this typically matter only to investors following the company closely and rarely have a meaningful effect on the broader market.

tags

instruments

STAAR Surgical

sources

  1. STAAR Surgical Company Stock 12‑Month Price Target Cut to $28.14, Implies 16% Upside — TradingView, 21 November 2026 at 04:20 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗